Revance Therapeutics settlements

A Revance Therapeutics securities class action settlement of $17,000,000 has been reached covering investors who purchased or acquired Revance Therapeutics common stock (ticker: RVNC) or 1.75% fixed coupon convertible senior unsecured notes between February 29, 2024 and February 6, 2025 — the period surrounding the Crown Laboratories merger. Individual payout amounts will depend on the total number of valid claims submitted and the allocation plan approved by the court. Proof documentation is required to file. The official claim deadline is August 28, 2026 — submit your claim through the verified form before that date.

Check what you may be owed Free · takes 20 seconds

Published directory

1 published record

Proof required

Antitrust

Revance Therapeutics Merger Securities Settlement

If you bought Revance Therapeutics stock (RVNC) or its convertible notes between February 29, 2024 and February 6, 2025, you can file a claim for a share of a $17 million settlement. The deadline to file is August 28, 2026, and you must submit a claim form — nothing happens automatically.

Related companies with published settlements

Share this collection — free to repost with a link back.

There may be money with your name on it.

Free to browse and track. Every record shows its official-evidence status — and you open the official claim form yourself.

Check what you may be owed Browse all settlements